Our Blog

International Clinical Trials Day

Today marks International Clinical Trials Day which commemorates the anniversary of the first clinical trial, conducted by James Lind in 1747, testing the efficacy of citrus fruit […]

How to Spot the Early Signs of Alzheimer’s

Webinar – How to Spot the Early Signs of Alzheimer’s   Re:Cognition Health is delighted  to host a free webinar on “How to Spot the Early Signs […]

Medical Cannabis Service Launch

Re:Cognition Health launches national Medical Cannabis Service   Re:Cognition Health is delighted to launch its national Medical Cannabis Service, designed to help alleviate persistent pain and other symptoms related to physical, […]

Dr Paschos Discusses Medical Cannabis

Dr Paschos Discusses Medical Cannabis   Consultant Psychiatrist Dr Dimitrios Paschos speaks with National World about the use of medicinal cannabis in the UK, which explores the […]

Carer’s Allowance

  There are many benefits available for the carers  of those  living with dementia, but navigating this complex system can be challenging. Our team at Re:Cognition Health […]

Tips for Dementia Carers

Tips for Carers Caring for an individual with Alzheimer’s can be rewarding but can also often be challenging,  presenting a myriad of emotions and obstacles along the […]

Neuroimaging in 2021

Neuroimaging in 2021 – Mild Traumatic Brain Injury (mTBI) – Unlocking the complexities: Webinar for  The Brain Injury Group   Dr Emer MacSweeney, Medical Director and Consultant […]

“Spotting the Early Signs and Supporting Your Patients” – Oryon Develop webinar

Dr Emer MacSweeney presented an Oryon Develop webinar on “Alzheimer’s – Spotting the Early Signs and Supporting Your Patients” targeted at healthcare practitioners.   The comprehensive presentation […]

CHUMS CHARITY

Our team at Re:Cognition Health is  passionate to support the health and learning of children and young people. Prior to the pandemic, one in nine children and […]

The Spectrum of Alzheimer’s

The Spectrum of Alzheimer’s   A recent study, undertaken by a Re:Cognition Health USA Principal Investigator Dr R. Scott Turner, confirms that both Mild Cognitive Impairment (MCI) […]